Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021
Frontiers in Oncology · 20.10.2025 · 15
DOI: 10.3389/fonc.2025.1623926 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.10.2025. Verfasst von Huishan Han und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
High body mass index (BMI) is a well-established risk factor for ovarian and uterine cancer. However, the global, regional, and national burden of these cancers attributable to high BMI remains underexplored. This study quantifies the trends and disparities in the burden of ovarian and uterine cancer due to high BMI from 1990 to 2021 using the Global Burden of Disease (GBD) 2021 dataset.
Methods
We extracted data from GBD 2021 to estimate the mortality, incidence, and disability-adjusted life years (DALYs) attributable to high BMI for ovarian and uterine cancer across different locations and time periods. We focused on the burden of ovarian and uterine cancers among women aged 20-49. Age-standardized rates (ASRs) were calculated, and temporal trends were analyzed using the estimated annual percentage change (EAPC). Regional and national disparities were assessed using sociodemographic index (SDI) classifications. Forecasts employed the exponential smoothing (ES) and autoregressive integrated moving average (ARIMA) models.
Results
Globally, the burden of ovarian and uterine cancer attributable to high BMI increased substantially from 1990 to 2021, with variations across regions and countries. High-income and upper-middle-income regions exhibited the highest ASRs, whereas low-SDI countries showed increasing trends in recent years. The EAPC analysis indicated a growing burden in developing regions, reflecting the rising prevalence of obesity. Age-stratified analysis revealed that middle-aged and older adults bear the highest burden.
Conclusions
The global burden of ovarian and uterine cancer attributable to high BMI has increased significantly over the past three decades. Targeted interventions, including obesity prevention and cancer screening, are crucial for mitigating this burden, particularly in emerging high-risk regions. These findings underscore the need for urgent public health strategies to address obesity-related cancer risks worldwide.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Pharmacy, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
- Department of Pathology and Lab Medicine, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Zitieren
APA
Han, H., Hou, D., Lin, Q., Hao, X., Zhang, Z., & Peng, X. (2025). Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1623926
Vancouver
Han H, Hou D, Lin Q, Hao X, Zhang Z, Peng X. Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1623926
BibTeX
@article{Han2025,
author = {Han, Huishan and Hou, Dan and Lin, Qinghai and Hao, Xiaohe and Zhang, Zhenyu and Peng, Xun},
title = {Global burden of ovarian and uterine cancers attributable to high body-mass index in 204 countries and territories, 1990–2021},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1623926}
}
EUVIMED